Alzamend Neuro, Inc. — Investor Relations & Filings
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders. Its primary targets include Alzheimer's disease, Bipolar Disorder, Major Depressive Disorder (MDD), and Post-Traumatic Stress Disorder (PTSD). The company's pipeline consists of two therapeutic drug candidates licensed from the University of South Florida Research Foundation. AL001 is a patented ionic cocrystal technology delivering a therapeutic combination of lithium, proline, and salicylate. ALZN002 is a patented cell-based therapeutic vaccine designed to restore the patient's immunological system's ability to combat Alzheimer's disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEF 14A - ALZAMEND NEURO, INC. (0001677077) (Filer) | 2026-02-26 | English | |
| PRIMARY DOCUMENT | 2025-12-30 | English | |
| PRIMARY DOCUMENT | 2025-12-23 | English | |
| Interim / Quarterly Report 2026 | 2025-12-09 | English | |
| Board/Management Information 2025 | 2025-11-18 | English | |
| PRIMARY DOCUMENT | 2025-10-24 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 32896473 | DEF 14A - ALZAMEND NEURO, INC. (0001677077) (Filer) | 2026-02-26 | English | ||
|
2025
14 filings
| |||||
| 12965128 | PRIMARY DOCUMENT | 2025-12-30 | English | ||
| 12965129 | PRIMARY DOCUMENT | 2025-12-23 | English | ||
| 12965132 | Interim / Quarterly Report 2026 | 2025-12-09 | English | ||
| 12965133 | Board/Management Information 2025 | 2025-11-18 | English | ||
| 12965139 | PRIMARY DOCUMENT | 2025-10-24 | English | ||
| 12965134 | Regulatory Filings 2025 | 2025-10-14 | English | ||
| 12965153 | PRIMARY DOCUMENT | 2025-10-10 | English | ||
| 12965136 | Capital/Financing Update 2025 | 2025-10-09 | English | ||
| 12965137 | PRIMARY DOCUMENT | 2025-10-08 | English | ||
| 12965138 | Major Shareholding Notification 2025 | 2025-10-08 | English | ||
| 12965150 | Major Shareholding Notification 2025 | 2025-10-04 | English | ||
| 12965140 | PRIMARY DOCUMENT | 2025-10-04 | English | ||
| 12965141 | Major Shareholding Notification 2025 | 2025-10-01 | English | ||
| 12965142 | PRIMARY DOCUMENT | 2025-10-01 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
Alzamend Neuro, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35321/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35321 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35321 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35321 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35321}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Alzamend Neuro, Inc. (id: 35321)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.